Android app Apple app link

Kymera Therapeutics, Inc. (KYMR) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$28.55

south_east
-$5.03 (-14.98%)
Day's range
$28.34
Day's range
$33.48

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
12/05/2024 BMO Capital Etzer Darout $55.00 $44.08   24.77%
12/02/2024 Wells Fargo Derek Archila $57.00 $48.54   17.44%
09/27/2024 Oppenheimer Jeff Jones $56.00 $49.47   13.2%
08/26/2024 Wolfe Research Andy Chen $65.00 $47.78   36.04%
08/08/2024 H.C. Wainwright Andrew Fein $60.00 $40.31   48.85%
06/17/2024 H.C. Wainwright Andrew Fein $46.00 $32.29   42.46%
05/23/2024 Piper Sandler Edward Tenthoff $56.00 $34.84   60.76%
05/03/2024 Oppenheimer Jeff Jones $52.00 $36.30   43.25%
12/06/2022 Morgan Stanley Michael Turits $45.20 $29.11   55.27%
12/05/2022 Credit Suisse Richard Law $32.00 $29.11   9.93%
05/19/2021 UBS Eliana Merle $80.00 $43.20   85.19%

Kymera Therapeutics, Inc. FAQ's

Kymera Therapeutics, Inc. has been rated by research analysts at H.C. Wainwright, BMO Capital, Wells Fargo, Oppenheimer, Wolfe Research, Piper Sandler in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.